Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, doxorubicin induced cardiomyopathy, neoplasm, skin disorder	Not yet recruiting	Phase 1 / Phase 2	2026-01-29		NCT07370506

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Tanta University	261

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Tanta University	Tanta	Egypt	1

Clinical trials